In last trading session, Revolution Medicines Inc (NASDAQ:RVMD) saw 1.22 million shares changing hands with its beta currently measuring 1.45. Company’s recent per share price level of $39.19 trading at $0.37 or 0.95% at ring of the bell on the day assigns it a market valuation of $6.68B. That closing price of RVMD’s stock is at a discount of -0.77% from its 52-week high price of $39.49 and is indicating a premium of 60.6% from its 52-week low price of $15.44. Taking a look at company’s average trading volume volume of 1.50 million if we extend that period to 3-months.
Revolution Medicines Inc (NASDAQ:RVMD) trade information
Upright in the green during last session for gaining 0.95%, in the last five days RVMD remained trading in the green while hitting it’s week-highest on Thursday, 05/02/24 when the stock touched $39.19 price level, adding 1.04% to its value on the day. Revolution Medicines Inc’s shares saw a change of 36.65% in year-to-date performance and have moved 10.93% in past 5-day. Revolution Medicines Inc (NASDAQ:RVMD) showed a performance of 24.85% in past 30-days.
Revolution Medicines Inc (RVMD) estimates and forecasts
Statistics highlight that Revolution Medicines Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 97.93% of value to its shares in past 6 months, showing an annual growth rate of 17.62% while that of industry is 11.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to fall -34.50% from the last financial year’s standing.
10 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 1.44M for the same. And 10 analysts are in estimates of company making revenue of 1.48M in the next quarter. Company posted 7.01M and 3.82M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -36.05% during past 5 years.
RVMD Dividends
Revolution Medicines Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
